Eversept Partners’s MannKind Corp MNKD Stock Holding History

Eversept Partners’s Portfolio MNKD Stock Details MNKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,000	Closed	-$219K	–	99
2021 Q4	$219K	Buy	+50,000	New	+$231K	0.01%	106

Other funds holding MNKD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Eversept Partners's MNKD Position: Q1 2026 in Review

Eversept Partners sold out of MannKind Corp (MNKD) in Q1 2026, closing a stake of 1,852,563 shares — an estimated $10.5M sold.

Eversept Partners first reported a position in MNKD in Q1 2021 and held it in 9 quarters. The position peaked at $12.5M in Q3 2024. 250 funds tracked by Wall St. Rank hold MNKD as of Q1 2026.

Eversept Partners reported no remaining MannKind Corp position as of Q1 2026 after selling out during the quarter.
Eversept Partners sold 1,852,563 MannKind Corp shares in Q1 2026, an estimated $10.5M.
Eversept Partners first reported a position in MannKind Corp in Q1 2021 and held it in 9 quarters.
Eversept Partners's MannKind Corp position peaked at $12.5M in Q3 2024.
250 funds tracked by Wall St. Rank held MannKind Corp as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.